You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (4) |
Back to Search
A comparison of two different self immolative linker strategies in the design of lymph directing, triglyceride mimetic prodrugs of buprenorphine
- In: Short Communications A2 on Monday, 22 May 2017, 13:30-15:00
- At: Stockholm (Sweden) (2017)
- Type: Presentation
- By: HAN, Sifei (Monash University, Drug Delivery, Disposition and Dynamics, Parkville, Australia)
- Co-author(s): Sifei Han: Drug Delivery, Disposition and Dynamics, Monash University, Parkville, Australia
Luojuan Hu: Drug Delivery, Disposition and Dynamics, Monash University, Parkville, Australia
Tim Quach: Medicinal Chemistry, Monash University, Parkville, Australia
Shea Lim: Medicinal Chemistry, Monash University, Parkville, Australia
Natalie Trevaskis: Drug Delivery, Disposition and Dynamics, Monash University, Parkville, Australia
Jamie Simpson: Medicinal Chemistry, Monash University, Parkville, Australia
Christopher Porter: Drug Delivery, Disposition and Dynamics, Monash University, Parkville, Australia - Abstract:
Backgrounds
The oral bioavailability of buprenorphine (BUP) is limited by hepatic first-pass metabolism. Exploiting drug transport through the lymphatic system provides a means to circumvent first pass metabolism, since the intestinal lymph drains into the systemic circulation via the thoracic duct, bypassing the liver. Previous studies have
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026